Clinical Trial Update: Low Dose of Diltiazem for Rate Control of Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating low-dose diltiazem for rate control in atrial fibrillation; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Diltiazem (diltiazem)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Atrial Fibrillation | Phase 4 | Status: UNKNOWN